Hims & Hers Health Inc.

NYSE: HIMS · Real-Time Price · USD
53.42
0.06 (0.11%)
At close: May 28, 2025, 3:59 PM
53.78
0.68%
After-hours: May 28, 2025, 06:21 PM EDT

Company Description

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals.

The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers.

It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care.

The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category.

In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners.

The company is based in San Francisco, California.

Hims & Hers Health Inc.
Hims & Hers Health Inc. logo
Country United States
IPO Date Sep 13, 2019
Industry Household & Personal Products
Sector Consumer Defensive
Employees 1,637
CEO Andrew Dudum

Contact Details

Address:
2269 Chestnut Street
San Francisco, California
United States
Website https://www.forhims.com

Stock Details

Ticker Symbol HIMS
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001773751
CUSIP Number 433000106
ISIN Number US4330001060
Employer ID 00-0000000
SIC Code 8011

Key Executives

Name Position
Andrew Dudum Co-Founder, Chairman & Chief Executive Officer
Mohamed ElShenawy Chief Technology Officer
Oluyemi Okupe Chief Financial Officer
Soleil Teubner Boughton J.D. Chief Legal Officer & Corporate Secretary
Dr. Patrick Carroll M.D. Chief Medical Officer & Director
Dr. Peter Stahl M.D. Senior Vice President of Men's Reproductive & Sexual Health
Irene A. Becklund Senior Vice President, Controller & Principal Accounting Officer
Khobi Brooklyn Chief Communications Officer
Mike Chi Chief Commercial Officer
Nader Kabbani Chief Operations Officer

Latest SEC Filings

Date Type Title
May 27, 2025 4 Filing
May 20, 2025 4 Filing
May 20, 2025 3 Filing
May 19, 2025 4 Filing
May 19, 2025 4 Filing
May 14, 2025 4 Filing
May 14, 2025 3 Filing
May 13, 2025 8-K Current Report
May 13, 2025 4 Filing
May 13, 2025 4 Filing